Primitive haemopoietic cells are required for studies in both the clinical and research fields and a number of systems have been developed to facilitate isolation of these haemopoietic cell populations. We have analysed the results from several European centres using positive selection of CD34 ؉ cells from haemopoietic tissues (n ‫؍‬ 110). Four selection techniques including immunoaffinity columns (Ceprate LC), immunomagnetic beads (Dynabeads, Baxter Isolex 50) and submicroscopic magnetic beads (MACS) were used and the selected CD34 ؉ cells were assessed for purity, yield and enrichment of colony-forming cells (CFC). The mean purities for all samples ranged from 68.4-78.4% for MACS, 33.9-69.9% for Dynabeads, 46.9-66.8% for Ceprate LC and 43.2-65% for Baxter Isolex 50. Yields were variable with all techniques. On average CFC enrichment using the immunoaffinity columns was greater than that observed for the other systems. Some techniques appear to be problematic and may require further expertise to improve the results. Nevertheless, the study demonstrates that highly purified CD34 ؉ cells can be isolated from various haemopoietic sources, though yield and CFC enrichment varies significantly depending on the technique selected. This extends our previous report indicating that not all selection methods generate similar results and that there are differences in the purity, number and colony-forming ability of the cells recovered. Keywords: CD34 + cells; positive selection; colony-forming cells; peripheral blood progenitor cells; umbilical cord blood; bone marrow Peripheral blood progenitor cells (PBPC) are used to reconstitute haemopoiesis after high-dose chemotherapy in both the autologous and allogeneic settings. As the time to engraftment is generally shorter than when bone marrow is used, the number of PBPC transplants performed each year has increased rapidly and they are gradually replacing auto- logous bone marrow transplants. Interest has also focussed on umbilical cord blood as another rich source of cells for transplantation and, to date, more than 600 of these transplants have been performed, primarily in children.
logous bone marrow transplants. Interest has also focussed on umbilical cord blood as another rich source of cells for transplantation and, to date, more than 600 of these transplants have been performed, primarily in children. [1] [2] [3] The CD34 antigen is expressed on virtually all haemopoietic progenitor cells and their precursors and normal bone marrow, umbilical cord blood and PBPC grafts contain varying numbers of CD34 + cells. The isolated CD34 + cells can reconstitute haemopoiesis in humans following myeloablative chemotherapy, indicating that the cells responsible for short-term and long-term engraftment must reside within the CD34 + compartment. 4 This led to the use of CD34-positive cell selection as a method for durable engraftment after highdose chemotherapy. [4] [5] [6] The functional properties of CD34 + cells have been widely studied and many transplant centres now rely only on the enumeration of CD34 + cells as an indicator for both optimal timing of PBPC harvests and haemopoietic reconstitutive capacity. 7, 8 There are many scientific and clinical applications for the isolated cells. Mechanisms involved in control of proliferation, differentiation, malignant transformation and gene transfection can be studied and culture conditions optimized for ex vivo expansion to generate appropriate numbers of cells required for transplantation. [9] [10] [11] [12] Extensive amplification and self-renewal of primitive cells such as LTC-IC have been reported and more recently megakaryocyte precursors generated from CD34 + cells were safely administered to PBPC transplant recipients. [13] [14] [15] [16] Renewed interest in immunotherapy coupled with the ability to generate dendritic cells from CD34 + cells has resulted in a variety of protocols to obtain dendritic cells for transplantation or vaccination. [17] [18] [19] [20] This has led to demands for reliable and reproducible methods for isolation and manipulation of defined haemopoietic cell populations.
CD34 + cells present unique problems due to the fact that they are present in haemopoietic tissues in extremely small numbers. [21] [22] [23] Most of the systems available for isolation are based on incubation with monoclonal antibodies against the CD34 antigen and subsequent binding of the target cells to columns or magnetic beads. 4, [24] [25] [26] Using small scale devices the best methods for positive selection or negative depletion can be established and adapted to large-scale procedures. We have reported previously our experience using five different methods for CD34
+ separation and now extend this comparison to a wider study involving several European Centres.
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Materials and methods
Samples
Samples of umbilical cord blood, normal bone marrow or apheresis harvests from patients with malignancies were obtained by individual centres in accord with their own Ethical Approval guidelines. All samples were processed within 24 h.
Participating centres
Seven laboratories participated in this work. Two from the United Kingdom, three in Italy, and two in Denmark. The study group included workers in clinical laboratories, research institutes and university departments. Each laboratory was required to return a form for individual experiments detailing source of the material for separation, numbers of mononuclear cells obtained and the percentage of CD34
+ cells in the input population. The number of cells recovered and the purity of the enriched population after the isolation procedure were recorded. Enrichment of clonogenic progenitor cells, CFC, was monitored by comparing the number of colonies grown from the unfractionated samples with the number of colonies obtained in the purified CD34
+ population. The information returned was from experiments which had been performed routinely in the participating laboratories.
CD34
+ cell selection Low-density mononuclear cells were obtained by removing the cells at the interface after density centrifugation over Ficoll. The cells were then processed according to the manufacturers' protocol for each of the selection procedures as detailed elsewhere. 27 
Immunoaffinity columns (Ceprate LC)
Briefly, for the selection of CD34 + cells by immunoaffinity on avidin columns (Ceprate LC; CellPro, Bothell, WA, USA) the mononuclear cells were treated with a biotinylated anti-CD34 monoclonal antibody (12.8, IgM). The cell mixture was washed, loaded on to avidin columns and the labelled cells were adsorbed. After washing the column to remove nonspecifically bound cells, target cells were released by manually squeezing the gel column.
Baxter Isolex 50
To select CD34 + cells using the Baxter Isolex 50 Magnetic Cell Separation System (Baxter, Santa Ana, CA, USA), mononuclear cells were incubated with an anti-CD34 monoclonal antibody (9C5), washed and further incubated with anti-mouse coated paramagnetic beads (Dynal, Oslo, Norway). The CD34-labelled cells coupled to the beads are retained using a strong magnet and CD34-negative cells removed by repeated washes. Bound cells were detached from the beads by treatment with chymopapain.
MiniMACS columns
CD34
+ cells were isolated using a colloidal suspension of super-paramagnetic microbeads in the MiniMACS CD34 Isolation Kit system (Miltenyi Biotec, Bergisch Gladbach, Germany). Mononuclear cells were labelled with the CD34 antibody (QBEND 10) and the blocking reagent provided. After washing, cells were incubated with the colloidal suspension of submicroscopic magnetic beads. After further washing, the cell suspension was passed through a column held in a magnetic field where the labelled target cells were retained. CD34 + cells were recovered by releasing the magnetic field and flushing the target cells from the column.
Dynabeads
The direct method for isolation of CD34
+ cells was used. Briefly, the mononuclear cells were incubated with Dynabeads coated with the CD34 antibody (BI3C5) for 45 min with constant rotation. The rosetted CD34 + cells were washed by placing the tube on a magnet and the nonrosetted cells removed by aspiration. This washing procedure was repeated several times and the CD34 + cells finally released from the beads by incubation with DETACHaBEAD (Dynal) at a dilution of 1:10. Beads were washed several times to collect residual cells.
FACS analysis
Flow cytometric analyses were performed before and after CD34
+ cell selection for all samples. Cells were stained following standard protocols with a phycoerythrin (PE)-conjugated antibody (HPCA-2, Becton Dickinson, San Jose, CA, USA) recommended by the suppliers of the selection devices, which does not interfere with the antibodies used for enrichment.
Clonogenic assays
Clonogenic assays for granulocyte-macrophage colony-forming cells (GM-CFC) and burst forming units-erythroid (BFU-E) were performed and scored 'in-house' using established methods and standard criteria.
Statistical analysis
Laboratories were arbitrarily coded from 1 to 7. Data for each laboratory and results from the techniques were assessed using standard linear models methodology. The basic additive model was taken as the starting point for the analysis: Mean (response) = X + S + T, where response = logit (purity), logit (yield) and CFC enrichment fold, respectively' X = log10 (CD34 + % in the unseparated population), S = Source (LH, CB, BM), T = technique.
The source and input percentage of CD34 + cells in the unseparated population was adjusted for in all analyses and a multiple comparison procedure for pairwise comparison between techniques in relation to purity, yield and CFC enrichment performed.
Results
CD34
+ cells were isolated from different haemopoietic sources including aphereses, bone marrow and cord blood using the commercial selection systems. The data from a total of 109 experiments were analysed for purity of CD34 + selected cells and cell yield for each of the techniques used. As the majority of CFC reside within the CD34 + population, the CFC content of isolated CD34
+ cells was compared with unseparated cells in order to calculate CFC enrichment.
Immunoaffinity columns (Ceprate LC)
Apheresis samples (n = 11), bone marrow (n = 6) and cord blood (n = 13) were processed at four different centres and results are detailed in Table 1 . The mean input of CD34 + cell content for apheresis (LH), bone marrow (BM) and cord blood (CB) samples was 1.5%, 0.9% and 0.8%, respectively. After separation on the immunoaffinity columns the adsorbed fractions were highly enriched for CD34
+ cells (26-98-fold). There was a wide variation in the yield of CD34 + cells recovered from the input population. Two centres reported final yields ranging from 30% to 74%, while the remaining laboratories were unable to recover more than 12% of the input CD34 + cell numbers (Table 1) . Close examination of the data indicated that centre 1 was experiencing some difficulty with this technique as yields were low regardless of the sample source. However, where colony assays were performed all centres achieved good enrichment of CFC. 
MiniMACS
Five centres were routinely using the MACS immunomagnetic separation technique. Results shown in Table 2 are a summary of 41 experiments. Good purities were achieved by all participating centres for all samples, with mean purities ranging from 61.3%-94.5% and enrichment from 17-135-fold. The values for purity were more consistent than those seen with the immunoaffinity columns ( Table  1) . On average, more than 50% of the input CD34 + cell numbers were recovered from CB and BM, with lower yields again observed with the LH samples (mean 22.7%). Although CFC enrichment in the cord blood samples was similar to that obtained with the immunoaffinity columns, enrichment of CFC for both LH and BM samples was reduced. Despite a three-fold increase in the input numbers of bone marrow CD34 + cells, (compare input of bone marrow CD34
+ cells with immunoaffinity columns, Table 1 ) the CFC enrichment was lower.
Dynabeads
Four centres used Dynabeads as one of the selection methods and Table 3 summarises a total of 33 experiments. From the results it was clear that one of the four centres had some difficulties with this method. Whilst centres 3 and 4 achieved mean purities comparable with the other selection systems, the results from the remaining laboratories were low. This was not due to a reduction in CD34 + input numbers as the percentage input from all centres was comparable. Two of the four centres had CD34 + cell yields below 30% for all samples with one of the participating laboratories reporting exceptionally low values for bone marrow and cord blood. When the mean yield was compared values ranged from 31.2-40.3%. CFC enrichment was poor for bone marrow and cord blood samples.
European study comparing CD34
+ selection techniques EA de Wynter et al 1194 Techniques are ordered from left to right with the best performance on the right. In the above, techniques not connected with a line are significantly different at the 5% level (P = 0.05) having adjusted for the %CD34 + in the input.
Baxter Isolex 50
Only five experiments were reported from two centres using this method, LH (n = 3) and CB (n = 2). The percentage input of CD34 + cells was similar and purities averaged 43.2% and 65% for LH and CB, respectively, but the mean yield was low, 10.4% and 11.6% regardless of sample source.
Statistics
Exploratory plots revealed that there was a clear association between the percentage of CD34 + cells in the unseparated population and that obtained in the separated population (ie purity). Spearman's rank correlation coefficient = 0.40 (P Ͻ 0.005). It was necessary to allow for this in the analysis of technique and source. For purity, the basic additive model, outlined in Materials and methods, needed to be augmented with a technique × source interaction (P = 0.0005). That is to say that the differences between the techniques varied with source of sample. Because of this, the analysis was performed separately for each source. Similar analyses were performed for yields (interaction P = 0.05). Results from multiple comparisons between techniques having adjusted for the CD34 content of the input are summarised in Table 4 . There was much less data available for analysis of CFC enrichment and after adjusting for the source of material, no significant differences were determined between the techniques (P = 0.37).
Discussion
Over the past few years CD34
+ cell selection has been reported for a number of different isolation systems where the methods differ in procedures and the CD34 antibodies employed. We have reported differences in the performance of the commercially available devices in terms of purity, yield and CFC enrichment in the Paterson Institute. 27 The present report extended that work in a multicentre study, and assessed more than 100 experiments from European groups who use similar small scale selection techniques on a regular basis. The overall results are in broad agreement with our previously reported data.
Five centres used the MiniMACS technique for positive selection of CD34 + cells and all obtained good purities ranging from 40.6% to 98.0% irrespective of the source of the sample. These results compare favourably with other studies. [27] [28] [29] [30] There were wide variations in purity for both the Ceprate affinity columns and the Dynal immunomagnetic beads and the results were less consistent than those using MiniMACS. Only five experiments were performed with the Isolex 50 magnetic beads where the purities fell within the reported range. 31, 32 All centres using the MiniMACS columns obtained good yields in agreement with the findings of other investigators. 12, [28] [29] [30] 33, 34 Though yields from Dynabeads and the Ceprate columns varied widely, those of the Ceprate columns were within the range reported in other studies. 29, 33, 35 Low yields may be a result of poor mechanical separation where cells are lost, or lack of expertise with particular techniques, and will affect both yield and final product purity. In addition, problems arise when making comparisons with published data as yields are often calculated simply as numbers of cells recovered after selection, divided by the number of cells in the starting population with no account taken of the purity of the recovered CD34
+ population as we have done. The former method often results in an overestimate of the CD34 + cells recovered, as the final product contains not only CD34-positive cells but also varying numbers of CD34-negative cells.
In the clinic a pre-requisite of isolation techniques is that the procedure should not induce substantial loss of primitive cells and for this reason the clonogenic cell content of the grafts has been measured before and after separation. However, as good correlation has been reported between the number of CD34 + cells and the GM-CFC (granulocytemacrophage colony-forming cell) content in aphereses, enumeration of CD34 + cells is now being used to estimate the progenitor cell content. 7, 8, 36, 37 In this study, the CFC enrichment was assessed using standard clonogenic assays and it was clear that all separation systems could generate cell populations enriched in their CFC content, expressed as fold increase. This is one of the more difficult parameters of small scale selection to compare with published work as it is not measured routinely, probably due to the time required for in vitro colony growth, since isolated cells are often required for immediate use. Nevertheless, when CD34 + cells purified by immunomagnetic and immunoadsorption techniques were compared, no difference was observed in the yield of GM-CFC in the purified populations. 38 From statistical analysis of the results, there was a clear association between the CD34 + cell percentage in the unseparated samples and that obtained in the isolated populations. This is in agreement with other studies where the final purity of selected cells correlated with the percentage of CD34
+ cells in the input population. 28, 30 There was also a significant difference between techniques regarding purity and yield of CD34 + cells, though in general MiniMACS performed best, again in agreement with previously published results. 27, 33 Overall most of the participating laboratories could obtain enriched CD34 + populations though workers agree there is a learning curve for these systems and time and acquired experience are needed before consistent results are achieved. Column techniques were quick, relatively easy and gave good results in a short time, whereas immunomagnetic bead separations probably require more expertise with a longer learning curve. Current applications of selection concern purging the grafts to remove tumour cells and it now seems that the selection process may be critical in this respect as significant differences were observed between immunomagnetic and immunoaffinity techniques for purging tumour cells from marrow and apheresis samples. 28, 30, 31, 33 Preliminary data also suggest that certain subpopulations are preferentially selected by various techniques which will have a clear impact on clinical transplantation. Some of these questions are now being addressed at the research level using these small scale separation devices.
